Quality of life and effectiveness comparisons of thyroxine withdrawal, triiodothyronine withdrawal, and recombinant thyroid-stimulating hormone administration for low-dose radioiodine remnant ablation of differentiated thyroid carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/20151824

Download in:

View as

General Info

PMID
20151824